IBDEI2LZ ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,41661,1,3,0)
;;=3^Parkinson's disease
;;^UTILITY(U,$J,358.3,41661,1,4,0)
;;=4^G20.
;;^UTILITY(U,$J,358.3,41661,2)
;;=^5003770
;;^UTILITY(U,$J,358.3,41662,0)
;;=G21.4^^155^2061^75
;;^UTILITY(U,$J,358.3,41662,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41662,1,3,0)
;;=3^Vascular parkinsonism
;;^UTILITY(U,$J,358.3,41662,1,4,0)
;;=4^G21.4
;;^UTILITY(U,$J,358.3,41662,2)
;;=^5003776
;;^UTILITY(U,$J,358.3,41663,0)
;;=I69.051^^155^2061^43
;;^UTILITY(U,$J,358.3,41663,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41663,1,3,0)
;;=3^Hemiplga fol ntrm subarach hemor aff right dominant side
;;^UTILITY(U,$J,358.3,41663,1,4,0)
;;=4^I69.051
;;^UTILITY(U,$J,358.3,41663,2)
;;=^5007409
;;^UTILITY(U,$J,358.3,41664,0)
;;=I69.052^^155^2061^41
;;^UTILITY(U,$J,358.3,41664,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41664,1,3,0)
;;=3^Hemiplga fol ntrm subarach hemor aff left dominant side
;;^UTILITY(U,$J,358.3,41664,1,4,0)
;;=4^I69.052
;;^UTILITY(U,$J,358.3,41664,2)
;;=^5007410
;;^UTILITY(U,$J,358.3,41665,0)
;;=I69.053^^155^2061^44
;;^UTILITY(U,$J,358.3,41665,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41665,1,3,0)
;;=3^Hemiplga fol ntrm subarach hemor aff right nondom side
;;^UTILITY(U,$J,358.3,41665,1,4,0)
;;=4^I69.053
;;^UTILITY(U,$J,358.3,41665,2)
;;=^5007411
;;^UTILITY(U,$J,358.3,41666,0)
;;=I69.054^^155^2061^42
;;^UTILITY(U,$J,358.3,41666,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41666,1,3,0)
;;=3^Hemiplga fol ntrm subarach hemor aff left nondom side
;;^UTILITY(U,$J,358.3,41666,1,4,0)
;;=4^I69.054
;;^UTILITY(U,$J,358.3,41666,2)
;;=^5007412
;;^UTILITY(U,$J,358.3,41667,0)
;;=I50.41^^155^2062^1
;;^UTILITY(U,$J,358.3,41667,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41667,1,3,0)
;;=3^Acute combined systolic and diastolic (congestive) hrt fail
;;^UTILITY(U,$J,358.3,41667,1,4,0)
;;=4^I50.41
;;^UTILITY(U,$J,358.3,41667,2)
;;=^5007248
;;^UTILITY(U,$J,358.3,41668,0)
;;=I50.31^^155^2062^2
;;^UTILITY(U,$J,358.3,41668,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41668,1,3,0)
;;=3^Acute diastolic (congestive) heart failure
;;^UTILITY(U,$J,358.3,41668,1,4,0)
;;=4^I50.31
;;^UTILITY(U,$J,358.3,41668,2)
;;=^5007244
;;^UTILITY(U,$J,358.3,41669,0)
;;=I50.43^^155^2062^3
;;^UTILITY(U,$J,358.3,41669,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41669,1,3,0)
;;=3^Acute on chronic combined systolic and diastolic hrt fail
;;^UTILITY(U,$J,358.3,41669,1,4,0)
;;=4^I50.43
;;^UTILITY(U,$J,358.3,41669,2)
;;=^5007250
;;^UTILITY(U,$J,358.3,41670,0)
;;=I50.33^^155^2062^4
;;^UTILITY(U,$J,358.3,41670,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41670,1,3,0)
;;=3^Acute on chronic diastolic (congestive) heart failure
;;^UTILITY(U,$J,358.3,41670,1,4,0)
;;=4^I50.33
;;^UTILITY(U,$J,358.3,41670,2)
;;=^5007246
;;^UTILITY(U,$J,358.3,41671,0)
;;=I50.23^^155^2062^5
;;^UTILITY(U,$J,358.3,41671,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41671,1,3,0)
;;=3^Acute on chronic systolic (congestive) heart failure
;;^UTILITY(U,$J,358.3,41671,1,4,0)
;;=4^I50.23
;;^UTILITY(U,$J,358.3,41671,2)
;;=^5007242
;;^UTILITY(U,$J,358.3,41672,0)
;;=I50.21^^155^2062^6
;;^UTILITY(U,$J,358.3,41672,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41672,1,3,0)
;;=3^Acute systolic (congestive) heart failure
;;^UTILITY(U,$J,358.3,41672,1,4,0)
;;=4^I50.21
;;^UTILITY(U,$J,358.3,41672,2)
;;=^5007240
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2LZ 3764 printed Oct 16, 2024@18:32:07 Page 2
IBDEI2LZ ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,41661,1,3,0)
+2 ;;=3^Parkinson's disease
+3 ;;^UTILITY(U,$J,358.3,41661,1,4,0)
+4 ;;=4^G20.
+5 ;;^UTILITY(U,$J,358.3,41661,2)
+6 ;;=^5003770
+7 ;;^UTILITY(U,$J,358.3,41662,0)
+8 ;;=G21.4^^155^2061^75
+9 ;;^UTILITY(U,$J,358.3,41662,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,41662,1,3,0)
+12 ;;=3^Vascular parkinsonism
+13 ;;^UTILITY(U,$J,358.3,41662,1,4,0)
+14 ;;=4^G21.4
+15 ;;^UTILITY(U,$J,358.3,41662,2)
+16 ;;=^5003776
+17 ;;^UTILITY(U,$J,358.3,41663,0)
+18 ;;=I69.051^^155^2061^43
+19 ;;^UTILITY(U,$J,358.3,41663,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,41663,1,3,0)
+22 ;;=3^Hemiplga fol ntrm subarach hemor aff right dominant side
+23 ;;^UTILITY(U,$J,358.3,41663,1,4,0)
+24 ;;=4^I69.051
+25 ;;^UTILITY(U,$J,358.3,41663,2)
+26 ;;=^5007409
+27 ;;^UTILITY(U,$J,358.3,41664,0)
+28 ;;=I69.052^^155^2061^41
+29 ;;^UTILITY(U,$J,358.3,41664,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,41664,1,3,0)
+32 ;;=3^Hemiplga fol ntrm subarach hemor aff left dominant side
+33 ;;^UTILITY(U,$J,358.3,41664,1,4,0)
+34 ;;=4^I69.052
+35 ;;^UTILITY(U,$J,358.3,41664,2)
+36 ;;=^5007410
+37 ;;^UTILITY(U,$J,358.3,41665,0)
+38 ;;=I69.053^^155^2061^44
+39 ;;^UTILITY(U,$J,358.3,41665,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,41665,1,3,0)
+42 ;;=3^Hemiplga fol ntrm subarach hemor aff right nondom side
+43 ;;^UTILITY(U,$J,358.3,41665,1,4,0)
+44 ;;=4^I69.053
+45 ;;^UTILITY(U,$J,358.3,41665,2)
+46 ;;=^5007411
+47 ;;^UTILITY(U,$J,358.3,41666,0)
+48 ;;=I69.054^^155^2061^42
+49 ;;^UTILITY(U,$J,358.3,41666,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,41666,1,3,0)
+52 ;;=3^Hemiplga fol ntrm subarach hemor aff left nondom side
+53 ;;^UTILITY(U,$J,358.3,41666,1,4,0)
+54 ;;=4^I69.054
+55 ;;^UTILITY(U,$J,358.3,41666,2)
+56 ;;=^5007412
+57 ;;^UTILITY(U,$J,358.3,41667,0)
+58 ;;=I50.41^^155^2062^1
+59 ;;^UTILITY(U,$J,358.3,41667,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,41667,1,3,0)
+62 ;;=3^Acute combined systolic and diastolic (congestive) hrt fail
+63 ;;^UTILITY(U,$J,358.3,41667,1,4,0)
+64 ;;=4^I50.41
+65 ;;^UTILITY(U,$J,358.3,41667,2)
+66 ;;=^5007248
+67 ;;^UTILITY(U,$J,358.3,41668,0)
+68 ;;=I50.31^^155^2062^2
+69 ;;^UTILITY(U,$J,358.3,41668,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,41668,1,3,0)
+72 ;;=3^Acute diastolic (congestive) heart failure
+73 ;;^UTILITY(U,$J,358.3,41668,1,4,0)
+74 ;;=4^I50.31
+75 ;;^UTILITY(U,$J,358.3,41668,2)
+76 ;;=^5007244
+77 ;;^UTILITY(U,$J,358.3,41669,0)
+78 ;;=I50.43^^155^2062^3
+79 ;;^UTILITY(U,$J,358.3,41669,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,41669,1,3,0)
+82 ;;=3^Acute on chronic combined systolic and diastolic hrt fail
+83 ;;^UTILITY(U,$J,358.3,41669,1,4,0)
+84 ;;=4^I50.43
+85 ;;^UTILITY(U,$J,358.3,41669,2)
+86 ;;=^5007250
+87 ;;^UTILITY(U,$J,358.3,41670,0)
+88 ;;=I50.33^^155^2062^4
+89 ;;^UTILITY(U,$J,358.3,41670,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,41670,1,3,0)
+92 ;;=3^Acute on chronic diastolic (congestive) heart failure
+93 ;;^UTILITY(U,$J,358.3,41670,1,4,0)
+94 ;;=4^I50.33
+95 ;;^UTILITY(U,$J,358.3,41670,2)
+96 ;;=^5007246
+97 ;;^UTILITY(U,$J,358.3,41671,0)
+98 ;;=I50.23^^155^2062^5
+99 ;;^UTILITY(U,$J,358.3,41671,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,41671,1,3,0)
+102 ;;=3^Acute on chronic systolic (congestive) heart failure
+103 ;;^UTILITY(U,$J,358.3,41671,1,4,0)
+104 ;;=4^I50.23
+105 ;;^UTILITY(U,$J,358.3,41671,2)
+106 ;;=^5007242
+107 ;;^UTILITY(U,$J,358.3,41672,0)
+108 ;;=I50.21^^155^2062^6
+109 ;;^UTILITY(U,$J,358.3,41672,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,41672,1,3,0)
+112 ;;=3^Acute systolic (congestive) heart failure
+113 ;;^UTILITY(U,$J,358.3,41672,1,4,0)
+114 ;;=4^I50.21
+115 ;;^UTILITY(U,$J,358.3,41672,2)
+116 ;;=^5007240
